TickerFacts.

Panacea Life Sciences Holdings, Inc. (PLSH): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$8.29M
As of 2023-12-31
$7.10M2014-12-31: $45.8K2015-12-31: -$93.3K2016-12-31: $1.50M2017-12-31: -$2.22M2018-12-31: -$3.42M2019-12-31: $4.43M2020-12-31: $6.71M2021-12-31: $7.10M2022-12-31: -$2.14M2023-12-31: -$8.29M-$8.29M
2014-12-31 Shareholders' Equity (USD) 2023-12-31
Period endedShareholders' EquityChange YoYSource filing
2023-12-31-$8.29Mn/m2024-04-01, Balance as of period end
2022-12-31-$2.14Mn/m2024-04-01, Balance as of period end
2021-12-31$7.10M+5.9%2023-03-30, Balance as of period end
2020-12-31$6.71M+51.6%2022-03-31, Balance as of period end
2019-12-31$4.43Mn/c2021-04-23, Balance as of period end
2018-12-31-$3.42Mn/m2020-05-22, Balance as of period end
2017-12-31-$2.22Mn/m2019-03-29, Balance as of period end
2016-12-31$1.50Mn/m2018-04-02, Balance as of period end
2015-12-31-$93.3Kn/m2017-03-31, Balance as of period end
2014-12-31$45.8Kn/a2016-02-29, Balance as of period end